Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
The microbiota in respiratory disease.

American journal of respiratory and critical care medicine

Erb-Downward JR, Huffnagle GB, Martinez FJ.
PMID: 22589308
Am J Respir Crit Care Med. 2012 May 15;185(10):1037-8. doi: 10.1164/rccm.201203-0567ED.

No abstract available.

Cite
Erb-Downward JR, Huffnagle GB, Martinez FJ. The microbiota in respiratory disease. Am J Respir Crit Care Med. 2012;185(10):1037-8doi: 10.1164/rccm.201203-0567ED.
Erb-Downward, J. R., Huffnagle, G. B., & Martinez, F. J. (2012). The microbiota in respiratory disease. American journal of respiratory and critical care medicine, 185(10), 1037-8. https://doi.org/10.1164/rccm.201203-0567ED
Erb-Downward, John R, et al. "The microbiota in respiratory disease." American journal of respiratory and critical care medicine vol. 185,10 (2012): 1037-8. doi: https://doi.org/10.1164/rccm.201203-0567ED
Erb-Downward JR, Huffnagle GB, Martinez FJ. The microbiota in respiratory disease. Am J Respir Crit Care Med. 2012 May 15;185(10):1037-8. doi: 10.1164/rccm.201203-0567ED. PMID: 22589308.
Copy Download .nbib Format: NLM
Deciphering the Lung Microbiome: Implications for Lung Health and Disease.

Respiration; international review of thoracic diseases

Johnson MM, Fernandez-Bussy S.
PMID: 30227431
Respiration. 2019;97(1):12-14. doi: 10.1159/000492753. Epub 2018 Sep 18.

No abstract available.

Cite
Johnson MM, Fernandez-Bussy S. Deciphering the Lung Microbiome: Implications for Lung Health and Disease. Respiration. 2018;97(1):12-14doi: 10.1159/000492753.
Johnson, M. M., & Fernandez-Bussy, S. (2019). Deciphering the Lung Microbiome: Implications for Lung Health and Disease. Respiration; international review of thoracic diseases, 97(1), 12-14. https://doi.org/10.1159/000492753
Johnson, Margaret M, and Fernandez-Bussy, Sebastian. "Deciphering the Lung Microbiome: Implications for Lung Health and Disease." Respiration; international review of thoracic diseases vol. 97,1 (2019): 12-14. doi: https://doi.org/10.1159/000492753
Johnson MM, Fernandez-Bussy S. Deciphering the Lung Microbiome: Implications for Lung Health and Disease. Respiration. 2019;97(1):12-14. doi: 10.1159/000492753. Epub 2018 Sep 18. PMID: 30227431.
Copy Download .nbib Format: NLM
Ventilator-Associated Pneumonia in Critically Ill Children: A New Paradigm.

Pediatric clinics of North America

Mourani PM, Sontag MK.
PMID: 28941534
Pediatr Clin North Am. 2017 Oct;64(5):1039-1056. doi: 10.1016/j.pcl.2017.06.005. Epub 2017 Aug 18.

Ventilator-associated pneumonia (VAP) is a serious complication of critical illness. Surveillance definitions have undergone revisions for more objective and consistent reporting. The 1 organism-1 disease paradigm for microbial involvement may not adequately apply to many cases of VAP, in...

Cite
Mourani PM, Sontag MK. Ventilator-Associated Pneumonia in Critically Ill Children: A New Paradigm. Pediatr Clin North Am. 2017;64(5):1039-1056doi: 10.1016/j.pcl.2017.06.005.
Mourani, P. M., & Sontag, M. K. (2017). Ventilator-Associated Pneumonia in Critically Ill Children: A New Paradigm. Pediatric clinics of North America, 64(5), 1039-1056. https://doi.org/10.1016/j.pcl.2017.06.005
Mourani, Peter M, and Sontag, Marci K. "Ventilator-Associated Pneumonia in Critically Ill Children: A New Paradigm." Pediatric clinics of North America vol. 64,5 (2017): 1039-1056. doi: https://doi.org/10.1016/j.pcl.2017.06.005
Mourani PM, Sontag MK. Ventilator-Associated Pneumonia in Critically Ill Children: A New Paradigm. Pediatr Clin North Am. 2017 Oct;64(5):1039-1056. doi: 10.1016/j.pcl.2017.06.005. Epub 2017 Aug 18. PMID: 28941534.
Copy Download .nbib Format: NLM
Harnessing the microbiome for lung health.

The Lancet. Respiratory medicine

The Lancet Respiratory Medicine.
PMID: 31556396
Lancet Respir Med. 2019 Oct;7(10):827. doi: 10.1016/S2213-2600(19)30307-8.

No abstract available.

Cite
The Lancet Respiratory Medicine. Harnessing the microbiome for lung health. Lancet Respir Med. 2019;7(10):827doi: 10.1016/S2213-2600(19)30307-8.
The Lancet Respiratory Medicine. (2019). Harnessing the microbiome for lung health. The Lancet. Respiratory medicine, 7(10), 827. https://doi.org/10.1016/S2213-2600(19)30307-8
The Lancet Respiratory Medicine. "Harnessing the microbiome for lung health." The Lancet. Respiratory medicine vol. 7,10 (2019): 827. doi: https://doi.org/10.1016/S2213-2600(19)30307-8
The Lancet Respiratory Medicine. Harnessing the microbiome for lung health. Lancet Respir Med. 2019 Oct;7(10):827. doi: 10.1016/S2213-2600(19)30307-8. PMID: 31556396.
Copy Download .nbib Format: NLM
Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia.

The Lancet. Respiratory medicine

Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, Asehnoune K.
PMID: 31182406
Lancet Respir Med. 2019 Aug;7(8):710-720. doi: 10.1016/S2213-2600(19)30140-7. Epub 2019 Jun 07.

Hospital-acquired pneumonia is a major cause of morbidity and mortality. The incidence of hospital-acquired pneumonia remains high globally and treatment can often be ineffective. Here, we review the available data and unanswered questions surrounding hospital-acquired pneumonia, discuss alterations of...

Cite
Roquilly A, Torres A, Villadangos JA, et al. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med. 2019;7(8):710-720doi: 10.1016/S2213-2600(19)30140-7.
Roquilly, A., Torres, A., Villadangos, J. A., Netea, M. G., Dickson, R., Becher, B., & Asehnoune, K. (2019). Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. The Lancet. Respiratory medicine, 7(8), 710-720. https://doi.org/10.1016/S2213-2600(19)30140-7
Roquilly, A, et al. "Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia." The Lancet. Respiratory medicine vol. 7,8 (2019): 710-720. doi: https://doi.org/10.1016/S2213-2600(19)30140-7
Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, Asehnoune K. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med. 2019 Aug;7(8):710-720. doi: 10.1016/S2213-2600(19)30140-7. Epub 2019 Jun 07. PMID: 31182406.
Copy Download .nbib Format: NLM
Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes.

Frontiers in immunology

Tirone C, Pezza L, Paladini A, Tana M, Aurilia C, Lio A, D'Ippolito S, Tersigni C, Posteraro B, Sanguinetti M, Di Simone N, Vento G.
PMID: 31921169
Front Immunol. 2019 Dec 12;10:2910. doi: 10.3389/fimmu.2019.02910. eCollection 2019.

In recent years, an aberrant gastrointestinal colonization has been found to be associated with an higher risk for postnatal sepsis, necrotizing enterocolitis (NEC) and growth impairment in preterm infants. As a consequence, the reasons of intestinal dysbiosis in this...

Cite
Tirone C, Pezza L, Paladini A, et al. Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes. Front Immunol. 2019;10:2910doi: 10.3389/fimmu.2019.02910.
Tirone, C., Pezza, L., Paladini, A., Tana, M., Aurilia, C., Lio, A., D'Ippolito, S., Tersigni, C., Posteraro, B., Sanguinetti, M., Di Simone, N., & Vento, G. (2019). Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes. Frontiers in immunology, 102910. https://doi.org/10.3389/fimmu.2019.02910
Tirone, Chiara, et al. "Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes." Frontiers in immunology vol. 10 (2019): 2910. doi: https://doi.org/10.3389/fimmu.2019.02910
Tirone C, Pezza L, Paladini A, Tana M, Aurilia C, Lio A, D'Ippolito S, Tersigni C, Posteraro B, Sanguinetti M, Di Simone N, Vento G. Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes. Front Immunol. 2019 Dec 12;10:2910. doi: 10.3389/fimmu.2019.02910. eCollection 2019. PMID: 31921169; PMCID: PMC6920179.
Copy Download .nbib Format: NLM
[Analysis of Pulmonary Microbial Diversity in Patients with Advanced Lung Cancer Based on High-throughput Sequencing Technology].

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Ran Z, Liu J, Wang F, Xin C, Shen X, Zeng S, Song Z, Xiong B.
PMID: 32758346
Zhongguo Fei Ai Za Zhi. 2020 Dec 20;23(12):1031-1038. doi: 10.3779/j.issn.1009-3419.2020.103.16. Epub 2020 Aug 06.

BACKGROUND: The pulmonary microbiome is closely related to the occurrence of pulmonary diseases. The morbidity and mortality of lung cancer are relatively high in the world. It has been confirmed that lung microecology changes in lung cancer patients compared...

Cite
Ran Z, Liu J, Wang F, et al. [Analysis of Pulmonary Microbial Diversity in Patients with Advanced Lung Cancer Based on High-throughput Sequencing Technology]. Zhongguo Fei Ai Za Zhi. 2020;23(12):1031-1038doi: 10.3779/j.issn.1009-3419.2020.103.16.
Ran, Z., Liu, J., Wang, F., Xin, C., Shen, X., Zeng, S., Song, Z., & Xiong, B. (2020). [Analysis of Pulmonary Microbial Diversity in Patients with Advanced Lung Cancer Based on High-throughput Sequencing Technology]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 23(12), 1031-1038. https://doi.org/10.3779/j.issn.1009-3419.2020.103.16
Ran, Zhuonan, et al. "[Analysis of Pulmonary Microbial Diversity in Patients with Advanced Lung Cancer Based on High-throughput Sequencing Technology]." Zhongguo fei ai za zhi = Chinese journal of lung cancer vol. 23,12 (2020): 1031-1038. doi: https://doi.org/10.3779/j.issn.1009-3419.2020.103.16
Ran Z, Liu J, Wang F, Xin C, Shen X, Zeng S, Song Z, Xiong B. [Analysis of Pulmonary Microbial Diversity in Patients with Advanced Lung Cancer Based on High-throughput Sequencing Technology]. Zhongguo Fei Ai Za Zhi. 2020 Dec 20;23(12):1031-1038. doi: 10.3779/j.issn.1009-3419.2020.103.16. Epub 2020 Aug 06. Chinese. PMID: 32758346; PMCID: PMC7786226.
Copy Download .nbib Format: NLM
Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis.

American journal of physiology. Lung cellular and molecular physiology

Willis KA, Stewart JD, Ambalavanan N.
PMID: 32877224
Am J Physiol Lung Cell Mol Physiol. 2020 Oct 01;319(4):L710-L716. doi: 10.1152/ajplung.00360.2020. Epub 2020 Sep 02.

A rapidly expanding new field of lung research has been produced by the emergence of culture-independent next-generation sequencing technologies. While pulmonary microbiome research lags behind the exploration of the microbiome in other organ systems, the field is maturing and...

Cite
Willis KA, Stewart JD, Ambalavanan N. Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis. Am J Physiol Lung Cell Mol Physiol. 2020;319(4):L710-L716doi: 10.1152/ajplung.00360.2020.
Willis, K. A., Stewart, J. D., & Ambalavanan, N. (2020). Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis. American journal of physiology. Lung cellular and molecular physiology, 319(4), L710-L716. https://doi.org/10.1152/ajplung.00360.2020
Willis, Kent A, et al. "Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis." American journal of physiology. Lung cellular and molecular physiology vol. 319,4 (2020): L710-L716. doi: https://doi.org/10.1152/ajplung.00360.2020
Willis KA, Stewart JD, Ambalavanan N. Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis. Am J Physiol Lung Cell Mol Physiol. 2020 Oct 01;319(4):L710-L716. doi: 10.1152/ajplung.00360.2020. Epub 2020 Sep 02. PMID: 32877224; PMCID: PMC7642895.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries